Evidence map›Paper›PMID 26086777›Full record

ArticlePloS one2015

The rs12526453 Polymorphism in an Intron of the PHACTR1 Gene and Its Association with 5-Year Mortality of Patients with Myocardial Infarction.

Anna Szpakowicz, Marek Kiliszek, Witold Pepinski, Ewa Waszkiewicz, Maria Franaszczyk, Malgorzata Skawronska, Rafal Ploski, Anna Niemcunowicz-Janica, Beata Burzynska, Dorota Tulacz and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Anna SzpakowiczDepartment of Cardiology, Medical University of Bialystok, Bialystok, Poland.
Marek Kiliszek1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland; Department of Cardiology and Internal Diseases, Military Institute of Medicine, Warsaw, Poland.
Witold PepinskiDepartment of Forensic Medicine, Medical University of Bialystok, Bialystok, Poland.
Ewa WaszkiewiczDepartment of Cardiology, Medical University of Bialystok, Bialystok, Poland.
Maria FranaszczykLaboratory of Molecular Biology, The Cardinal Stefan Wyszynski Institute of Cardiology, Warsaw, Poland.
Malgorzata SkawronskaDepartment of Forensic Medicine, Medical University of Bialystok, Bialystok, Poland.
Rafal PloskiDepartment of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
Anna Niemcunowicz-JanicaDepartment of Forensic Medicine, Medical University of Bialystok, Bialystok, Poland.
Beata BurzynskaInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Dorota TulaczInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Agata MaciejakInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Marcin Jakub KaminskiDepartment of Cardiology, Medical University of Bialystok, Bialystok, Poland.
Grzegorz Opolski1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Wlodzimierz Jerzy MusialDepartment of Cardiology, Medical University of Bialystok, Bialystok, Poland.
Karol Adam KaminskiDepartment of Cardiology, Medical University of Bialystok, Bialystok, Poland.
Medical University of Białystok · PLInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PLMedical University of Warsaw · PLInstitute of Cardiology · PLWojskowy Instytut Medycyny Lotniczej · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe rs12526453 (C/G) is a single nucleotide polymorphism in an intron of the PHACTR1 gene (phosphatase and actin regulator 1). The C allele is associated with increased risk of coronary artery disease in an unknown mechanism. We investigated its association with long-term overall mortality in patients with ST-elevation myocardial infarction (STEMI) treated invasively.

methodsTwo independent groups of patients with STEMI were analyzed: a derivation group (n= 638) and a validation one (n=348). Genotyping was performed with the TaqMan method. The analyzed end-point was total long term mortality. Additionally, transcriptomic analysis was performed in mononuclear blood leukocytes from rs12526453 CC monozygotes or G allele carriers.

resultsIn the study group (mean age 62.3 ± 11.9 years; 24.9% of females, n=159), percentages of CC, CG, and GG genotypes were 45.3% (n=289), 44.7% (n=285), and 10% (n=64), respectively. In the 5-year follow-up 105 patients died (16.46%). CC homozygotes had significantly lower mortality compared to other genotypes: 13.1% (n=38) vs. 18.3% in G-allele carriers (n=67), (p=0.017, Cox`s F test). In the validation group 47 patients died within 3 years (13.5%). We confirmed lower mortality of CC homozygotes: 10.1 % (n=18) vs. 16.95% in G-allele carriers (n=29), (p=0.031, Cox`s F test). Transcriptomic analysis revealed a markedly higher expression of NLRP-2 in CC homozygotes.

conclusionsThe rs12526453 CC homozygotes (previously associated with increased risk of myocardial infarction) showed, in 2 independent samples, better long-term survival. The finding of such high effect size, after appropriate validation, could potentially be translated into clinical practice.

Indexed as

Polymorphism, Single NucleotideAgedFemaleHumansIntronsMaleMicrofilament ProteinsMiddle AgedMyocardial InfarctionSurvival AnalysisMicrofilament ProteinsPHACTR1 protein, human

Identifiers

PMID26086777
PMCPMC4472810
OpenAlexW1875227791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.